Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002531 · ClinicalTrials.gov registry record · NA
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04002531 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 5 participants.
The verdict
NCT04002531, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The objective of this study is to obtain follow up data on a cohort of well-studied patients with Fabry disease who have been on ERT since childhood for a total of about 15 years.
Interventions
- PROCEDURE Echocardiogram
- PROCEDURE Blood draw
- OTHER General and Neurological examination
- OTHER Vital signs
- PROCEDURE 12 lead electrocardiogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-11-10 |
| Est. Completion | 2019-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04002531
The ClinicalTrials.gov registry entry for NCT04002531 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Echocardiogram is the first listed.
NCT04002531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04002531 about?
NCT04002531 is a clinical study titled "A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children". The objective of this study is to obtain follow up data on a cohort of well-studied patients with Fabry disease who have been on ERT since childhood for a total of about 15 years.
What is the current status of trial NCT04002531?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-11-10. Estimated completion is 2019-12-13.
What interventions are being tested in trial NCT04002531?
The interventions under investigation include: Echocardiogram (PROCEDURE), Blood draw (PROCEDURE), General and Neurological examination (OTHER), Vital signs (OTHER), 12 lead electrocardiogram (PROCEDURE).
Who is sponsoring clinical trial NCT04002531?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.